Literature DB >> 6029147

Glymidine.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6029147      PMCID： PMC1843097     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  GLYCODIAZINE IN DIABETES MELLITUS: A CLINICAL TRIAL.

Authors:  R D STEWART; D E ANDERSON
Journal:  Br Med J       Date:  1965-09-18

2.  [PHARMACOLOGY OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING COMPOUND].

Authors:  M KRAMER; G HECHT; H LANGECKER; A HARWART; K D RICHTER; C GLOXHUBER
Journal:  Arzneimittelforschung       Date:  1964-05

3.  [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].

Authors:  H GUTSCHE; G BOENICKE
Journal:  Arzneimittelforschung       Date:  1964-05

4.  [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].

Authors:  H BERNHARD
Journal:  Arzneimittelforschung       Date:  1964-05

5.  [REPORT ON THE CLINICAL TESTING OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].

Authors:  H LEUBNER
Journal:  Arzneimittelforschung       Date:  1964-05

6.  [ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].

Authors:  H ROBBERS; K H BRUMBY; K J TRAUMANN
Journal:  Arzneimittelforschung       Date:  1964-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.